News
Wedbush Maintains Outperform on Astria Therapeutics, Raises Price Target to $22
26 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Maintains $18 Price Target
25 Mar 24
News, Price Target, Analyst Ratings
Astria Therapeutics Announces Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
25 Mar 24
News
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
20 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $18 Price Target
14 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Reiterates Outperform on Astria Therapeutics, Maintains $17 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Astria Therapeutics, Maintains $18 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Astria Therapeutics Q4 EPS $(0.86) Down From $(0.72) YoY
4 Mar 24
Earnings, News
Wedbush Reiterates Outperform on Astria Therapeutics, Maintains $17 Price Target
30 Jan 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Thursday's Pre-Market Session
25 Jan 24
Movers
Press releases
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
25 Mar 24
Press Releases
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
4 Mar 24
Press Releases
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5 Feb 24
Press Releases
Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering
30 Jan 24
Press Releases